Bain Capital Life Sciences Investors’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,122,415
| Closed | -$48.9M | – | 27 |
|
|
2020
Q3 | $48.9M | Sell |
2,122,415
-40,183
| -2% | -$925K | 4.55% | 6 |
|
|
2020
Q2 | $53.7M | Sell |
2,162,598
-676,370
| -24% | -$16.8M | 5.63% | 6 |
|
|
2020
Q1 | $28.3M | Hold |
2,838,968
| – | – | 4.79% | 6 |
|
|
2019
Q4 | $40.7M | Hold |
2,838,968
| – | – | 6.08% | 5 |
|
|
2019
Q3 | $39.5M | Hold |
2,838,968
| – | – | 10.16% | 4 |
|
|
2019
Q2 | $41.6M | Hold |
2,838,968
| – | – | 21.14% | 2 |
|
|
2019
Q1 | $43.2M | Hold |
2,838,968
| – | – | 17.28% | 2 |
|
|
2018
Q4 | $28.4M | Hold |
2,838,968
| – | – | 9.7% | 5 |
|
|
2018
Q3 | $45.7M | Buy |
+2,838,968
| New | +$45.7M | 10.37% | 5 |
|